Literature DB >> 3110611

Investigations on DNA binding in rat liver and in Salmonella and on mutagenicity in the Ames test by emodin, a natural anthraquinone.

R Bösch, U Friederich, W K Lutz, E Brocker, M Bachmann, C Schlatter.   

Abstract

Emodin (1,6,8-trihydroxy-3-methylanthraquinone), an important aglycone found in natural anthraquinone glycosides frequently used in laxative drugs, was mutagenic in the Salmonella/mammalian microsome assay (Ames test) with a specificity for strain TA1537. The mutagenic activity was activation-dependent with an optimal amount of S9 from Aroclor 1254-treated male Sprague-Dawley rats of 20% in the S9 mix (v/v) for 10 micrograms emodin per plate. Heat inactivation of the S9 for 30 min at 60 degrees C prevented mutagenicity. The addition of the cytochrome P-448 inhibitor 7,8-benzoflavone (18.5 nmoles per plate) reduced the mutagenic activity of 5.0 micrograms emodin per plate to about one third, whereas the P-450 inhibitor metyrapone (up to 1850 nmoles per plate) was without effect. To test whether a metabolite binds covalently to Salmonella DNA, [10-(14)C]emodin was radiosynthesized, large batches of bacteria were incubated with [10-(14)C]emodin and DNA was isolated. [G-3H]Aflatoxin B1 (AFB1) was used as a positive control mutagen known to act via DNA binding. DNA obtained after aflatoxin treatment could be purified to constant specific activity. With emodin, the specific activity of DNA did not remain constant after repeated precipitations so that it is unlikely that the mutagenicity of emodin is due to covalent interaction of a metabolite with DNA. The antioxidants vitamin C and E or glutathione did not reduce the mutagenicity. Emodin was also negative with strain TA102. Thus, oxygen radicals are probably not involved. When emodin was incubated with S9 alone for up to 50 h before heat-inactivation of the enzymes and addition of bacteria, the mutagenic activity did not decrease. It is concluded that the mutagenicity of emodin is due to a chemically stable, oxidized metabolite forming physico-chemical associations with DNA, possibly of the intercalative type. In order to check whether an intact mammalian organism might be able to activate emodin to a DNA-binding metabolite, radiolabelled emodin was administered by oral gavage to male SD rats and liver DNA was isolated after 72 h. Very little radioactivity was associated with the DNA. Considering that DNA radioactivity could also be due to sources other than covalent interactions, an upper limit for the covalent binding index, CBI = (mumoles chemical bound per moles DNA nucleotides)/(mmoles chemical administered per kg body weight) of 0.5 is deduced. This is 10(4) times below the CBI of AFB1.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110611     DOI: 10.1016/0165-1218(87)90085-1

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  Does senna extract promote growth of aberrant crypt foci and malignant tumors in rat colon?

Authors:  N Mascolo; E Mereto; F Borrelli; P Orsi; D Sini; A A Izzo; B Massa; M Boggio; F Capasso
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Trenbolone growth promotant: covalent DNA binding in rat liver and in Salmonella typhimurium, and mutagenicity in the Ames test.

Authors:  W K Lutz; R Deuber; M Caviezel; P Sagelsdorff; U Friederich; C Schlatter
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

3.  Combined phytochemistry and chemotaxis assays for identification and mechanistic analysis of anti-inflammatory phytochemicals in Fallopia japonica.

Authors:  Ming-Yi Shen; Yan-Jun Liu; Ming-Jaw Don; Hsien-Yueh Liu; Zeng-Weng Chen; Clément Mettling; Pierre Corbeau; Chih-Kang Chiang; Yu-Song Jang; Tzu-Hsuan Li; Paul Young; Cicero L T Chang; Yea-Lih Lin; Wen-Chin Yang
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

Review 4.  Naturally occurring anthraquinones: chemistry and therapeutic potential in autoimmune diabetes.

Authors:  Shih-Chang Chien; Yueh-Chen Wu; Zeng-Weng Chen; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-18       Impact factor: 2.629

5.  Prediction of rodent carcinogenicity using the DEREK system for 30 chemicals currently being tested by the National Toxicology Program. The DEREK Collaborative Group.

Authors:  C A Marchant
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.